Newswise Feature Channel: Pharmaceuticals

Eight Early-Career Scientists Will Attend the AACR Annual Meeting with Ludwig Support

Ludwig Cancer Research — Fri, 25 Apr 2025 19:40:24 EST

Ludwig Cancer Research is proud to support eight early-career scientists presenting their research at the conference this year through the AACR Scholar-in-Training Awards (SITA) program, contributing to the cost of their travel and attendance at the conference.

Despite Its Efficacy, Efanesoctocog Alfa Not a Cost-Effective Choice in Treating Severe Hemophilia A

American College of Physicians (ACP) — Mon, 21 Apr 2025 17:00:00 EST

A cost-effectiveness analysis evaluated whether a newer and more efficacious treatment to prevent bleeding in those with severe hemophilia A, efanesoctocog alfa (Altuviiio), improves outcomes enough to justify its higher cost compared to standard-care factor VIII prophylaxis.

Most Patients with Newly Diagnosed Atrial Fibrillation During Hospitalization Not Dispensed Anticoagulants for Stroke Risk

American College of Physicians (ACP) — Mon, 21 Apr 2025 17:00:00 EST

A population-based retrospective cohort study described the use of anticoagulation and the risk for stroke after newly diagnosed atrial fibrillation (AF) during hospitalization for other causes among older patients.

K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate with Ultra-High Drug Loading Capacity Demonstrates Superior Efficacy in EGFR-Expressing Solid Tumors

Kowa Company Ltd. — Mon, 21 Apr 2025 10:05:06 EST

Kowa Company, Ltd. (Headquarters: Nagoya, Aichi Prefecture, Japan), today announced an upcoming presentation of non-clinical data for K-679, its novel antibody drug-loaded unimicelle conjugate (ADUC) with unprecedented drug loading capacity.

Comfortable in (bio)printed skin

University of Pretoria — Thu, 17 Apr 2025 20:50:51 EST

Wound healing has been termed "an overlooked burden and a silent epidemic" due to the significant financial strain that it places on healthcare systems, let alone the unquantifiable human cost.

GemPharmatech Significantly Expands U.S. Capabilities with New San Diego Biotech Hub Facility

GemPharmatech LLC — Thu, 17 Apr 2025 13:10:08 EST

GemPharmatech Significantly Expands U.S. Capabilities with New San Diego Biotech Hub Facility

Wesley Sundquist Named to TIME's Annual TIME100 List of the 100 Most Influential People in the World

University of Utah Health — Thu, 17 Apr 2025 13:05:26 EST

Research in the Sundquist lab laid the foundations for the development of lenacapavir, a drug that prevents HIV infection with 99.9% to 100% efficacy and could dramatically lower infection rates worldwide.

Direct-Acting Oral Anticoagulant and Antiseizure Medication Interactions: A Gray Zone in Epilepsy Treatment

International League Against Epilepsy — Thu, 17 Apr 2025 08:35:25 EST

As many as 10% of people with epilepsy taking antiseizure medications also take medications to lower the risk of blood clots. Many are prescribed direct-acting oral anticoagulants, or DOACs. But how DOACs interact with antiseizure medications, particularly newer-generation medications, is still not clear.

Inactive Components in Agricultural Runoff May Be Hidden Contributors to Drinking Water Hazards

Washington University in St. Louis — Tue, 15 Apr 2025 20:05:33 EST

A new study from researchers in the at Washington University in St. Louis reveals the impact of what might may be precursors to harmful contaminants in drinking water, formed during water disinfection.

You Can Heal More Wounds with Honey

Universite de Montreal — Tue, 15 Apr 2025 17:20:58 EST

UdeM pharmacy professor Simon Matoori has reviewed studies on the therapeutic properties of honey in the treatment of both acute and chronic wounds.

ProBio to Present Data on Its CD3 Agonistic Single Domain Antibody Platform for Accelerated Development of T Cell Engager Multi-Specific Antibodies

ProBio Inc. — Mon, 14 Apr 2025 10:30:40 EST

ProBio, a global leader in the antibody discovery and development, is pleased to announce its upcoming poster presentation at the American Association for Cancer ResearchⓇ (AACR) 116th Annual Meeting, to be held April 25 to 30, 2025, at the McCormick Place Convention Center in Chicago, Illinois.

Study Provides Scaffold to Selectively Target Drug Breakdown Process

St. Jude Children's Research Hospital — Thu, 10 Apr 2025 20:05:49 EST

Scientists at St. Jude Children's Research Hospital explored selectively blocking the CYP3A4 protein responsible for breaking down large swaths of approved drugs, providing a way to improve drug efficacy.

Pharma Tariff Implications: Risk Expert Clifford Rossi Available

University of Maryland, Robert H. Smith School of Business — Wed, 09 Apr 2025 18:30:22 EST

Stroke Patients Discharged from Hospital Sooner when Administered Revalesio's RNS60; New Statistically Significant Finding from Revalesio's Phase 2 Clinical Trial

Revalesio Corporation — Wed, 09 Apr 2025 09:05:08 EST

Results presented during oral presentation at the American Academy of Neurology 2025 Annual Meeting

Chemical Pollution Increases More Than 100-Fold After Sewage Discharges in South-Coast Waters

University of Portsmouth — Mon, 07 Apr 2025 02:35:00 EST

A worryingly wide range of chemical pollutants has been found by researchers studying two of the UK's south-coast harbours, raising concerns about the impact on wildlife and the human activities responsible for this contamination.

Virus Infects Cells with a Protective Cloaking Mechanism

University of California San Diego — Thu, 03 Apr 2025 20:40:06 EST

Viruses known as "jumbo phage" are a new hope against the rising antibacterial infection crisis. Researchers have discovered how jumbo phage are able to infect bacteria so efficiently. They found a compartment that protects and hides valuable DNA material from the bacteria's immune defense system.

New COVID-19 Drug Shows Greater Promise Against Resistant Viral Strains

Rutgers University-New Brunswick — Thu, 03 Apr 2025 19:40:19 EST

A second-generation compound outperforms predecessor in the fight against coronavirus.

Powerful New Software Platform Could Reshape Biomedical Research by Making Data Analysis More Accessible

Mount Sinai Health System — Thu, 03 Apr 2025 14:00:00 EST

A powerful new software platform called the Playbook Workflow Builder is set to transform biomedical research by allowing scientists to conduct complex and customized data analyses without advanced programming skills. An article that describes the new platform was published in the April 3 online issue of the journal PLOS Computational Biology. Developed by a multi-institutional team that was led by Icahn School of Medicine at Mount Sinai investigators as part of the National Institutes of Health Common Fund Data Ecosystem (CFDE) program, researchers from across the United States developed the web-based platform that enables scientists to analyze and visualize their own data independently through an intuitive, interactive interface.

New Book "I, Ovosan" Shares Stories of Hope & Resilience in Cancer Battle

Immod Innovations — Thu, 03 Apr 2025 11:20:00 EST

"I, Ovosan" offers inspiring cancer survivor stories interwoven with cutting-edge research, detailing the development and therapeutic potential of Ovosan's bioactive phospholipids, now available in the US as CellBB.

Nobel Laureate, Prestigious Award Recipients to Speak at American Physiology Summit

American Physiological Society (APS) — Thu, 03 Apr 2025 07:00:32 EST

Nobel Laureate James Rothman, PhD; Holly A. Ingraham, PhD, FASEB's 2024 Lifetime Achievement awardee; and George A. Brooks, PhD, FAPS, the American Physiological Society's (APS) 2025 Walter Cannon Award recipient, are among the highlighted speakers who will attend the American Physiology Summit. The Summit, APS' flagship annual meeting, will be held April 24-27 in Baltimore.